Literature DB >> 7510710

Growth-inhibitory effects of coumarin (1,2-benzopyrone) and 7-hydroxycoumarin on human malignant cell lines in vitro.

M E Marshall1, K Kervin, C Benefield, A Umerani, S Albainy-Jenei, Q Zhao, M B Khazaeli.   

Abstract

Coumarin (1,2-benzopyrone) is a natural substance that has shown antitumor activity in vivo. The major human metabolite of coumarin, 7-hydroxycoumarin (7-HC), is the active form of the drug. While the exact mechanism(s) of action of coumarin is unknown, it has been shown previously that this drug possesses immunomodulatory activity in vitro and in vivo. The present investigations examined the direct (non-immunological) antitumor effects of coumarin and 7-HC in vitro. Both coumarin and 7-HC were found to be growth-inhibitory (cytostatic) for the following human malignant cell lines: A549, ACHN, Caki-2, Dakiki, HS-Sultan, H727, HCT-15, HL-60, K562, LNCaP, PC-3, Du 145 COLO-232, MCF-7 and RP-1788. The growth inhibition was dependent on dose and time and was reversible upon removal of cells from medium containing the drug. Coumarin and 7-HC inhibited [3H]thymidine, [3H]uridine and [3H]leucine incorporation. In a similar fashion, coumarin and 7-HC inhibited the intracellular production of prostate-specific antigen by LNCaP cells. Coumarin and 7-HC stimulated apoptosis in HL-60 cells but not in other cell lines tested. It is concluded that coumarin and 7-HC have direct antitumor (cytostatic) activity as well as immunomodulatory activity. Further information is needed in order to determine which activities are responsible for antitumor activity in vivo.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7510710     DOI: 10.1007/bf01377114

Source DB:  PubMed          Journal:  J Cancer Res Clin Oncol        ISSN: 0171-5216            Impact factor:   4.553


  22 in total

1.  Cimetidine and coumarin therapy of melanoma.

Authors:  R D Thornes; G Lynch; M V Sheehan
Journal:  Lancet       Date:  1982-08-07       Impact factor: 79.321

2.  Combination of cimetidine with other drugs for treatment of cancer.

Authors: 
Journal:  N Engl J Med       Date:  1983-03-10       Impact factor: 91.245

3.  Phase II evaluation of coumarin (1,2-benzopyrone) in metastatic prostatic carcinoma.

Authors:  J L Mohler; L G Gomella; E D Crawford; L M Glode; C D Zippe; W R Fair; M E Marshall
Journal:  Prostate       Date:  1992       Impact factor: 4.104

4.  Treatment of advanced malignant melanoma with coumarin and cimetidine: a pilot study.

Authors:  M E Marshall; K Butler; J Cantrell; C Wiseman; L Mendelsohn
Journal:  Cancer Chemother Pharmacol       Date:  1989       Impact factor: 3.333

5.  Phase I evaluation of coumarin (1,2-benzopyrone) and cimetidine in patients with advanced malignancies.

Authors:  M E Marshall; K Butler; A Fried
Journal:  Mol Biother       Date:  1991-09

6.  The effect of coumarin derivatives on the immunological system of man.

Authors:  B Berkarda; H Bouffard-Eyüboğlu; U Derman
Journal:  Agents Actions       Date:  1983-02

7.  Effects of coumarin (1,2-benzopyrone) and cimetidine on peripheral blood lymphocytes, natural killer cells, and monocytes in patients with advanced malignancies.

Authors:  M E Marshall; L K Riley; J Rhoades; T Eichhorn; C D Jennings; M Cibull; J Thompson
Journal:  J Biol Response Mod       Date:  1989-02

8.  Effects of coumarin (1,2-benzopyrone) on lymphocyte, natural killer cell, and monocyte functions in vitro.

Authors:  M E Marshall; D Conley; P Hollingsworth; S Brown; J S Thompson
Journal:  J Biol Response Mod       Date:  1989-02

9.  Treatment of metastatic renal cell carcinoma with coumarin (1,2-benzopyrone) and cimetidine: a pilot study.

Authors:  M E Marshall; L Mendelsohn; K Butler; L Riley; J Cantrell; C Wiseman; R Taylor; J S Macdonald
Journal:  J Clin Oncol       Date:  1987-06       Impact factor: 44.544

10.  Cimetidine and coumarin therapy of renal cell carcinoma. A pilot study.

Authors:  O Kokron; S Maca; G Gasser; P R Schmidt
Journal:  Oncology       Date:  1991       Impact factor: 2.935

View more
  9 in total

1.  Towards identification of bioactive compounds in cold vacuum extracted double cherry blossom (Gosen-Sakura) leaves.

Authors:  Junko Shibato; Fumiko Takenoya; Takahiro Hirabayashi; Ai Kimura; Yusuke Iwasaki; Yoko Toyoda; Motohide Hori; Shigeru Tamogami; Randeep Rakwal; Seiji Shioda
Journal:  Plant Signal Behav       Date:  2019-07-25

2.  Suppression of the proliferation and migration of oncogenic ras-dependent cell lines, cultured in a three-dimensional collagen matrix, by flavonoid-structured molecules.

Authors:  H Q Lü; B Niggemann; K S Zänker
Journal:  J Cancer Res Clin Oncol       Date:  1996       Impact factor: 4.553

Review 3.  An updated review of the clinical development of coumarin (1,2-benzopyrone) and 7-hydroxycoumarin.

Authors:  M E Marshall; J L Mohler; K Edmonds; B Williams; K Butler; M Ryles; L Weiss; D Urban; A Bueschen; M Markiewicz
Journal:  J Cancer Res Clin Oncol       Date:  1994       Impact factor: 4.553

4.  Synthesis and Characterization of Some New Coumarins with in Vitro Antitumor and Antioxidant Activity and High Protective Effects against DNA Damage.

Authors:  Mounir A I Salem; Magda I Marzouk; Azza M El-Kazak
Journal:  Molecules       Date:  2016-02-22       Impact factor: 4.411

5.  New Samarium(III), Gadolinium(III), and Dysprosium(III) Complexes of Coumarin-3-Carboxylic Acid as Antiproliferative Agents.

Authors:  Irena Kostova; Georgi Momekov; Peya Stancheva
Journal:  Met Based Drugs       Date:  2007

6.  Oxidative Aromatization, Cytotoxic Activity Evaluation and Conformational Study of Novel 7-aryl-10, 11-dihydro-7H-chromeno [4, 3-b]quinoline-6, 8(9H, 12H)-dione Derivatives.

Authors:  Radineh Motamedi; Abbas Shafiee; Mohammad Reza Rezai; Omidreza Firuzi; Najmeh Edraki; Ramin Miri
Journal:  Iran J Pharm Res       Date:  2014       Impact factor: 1.696

7.  Evaluation of photoluminescence properties of some poly(ethylene glycol)-supported coumarin derivatives.

Authors:  Graziella Tocco; Carlo Maria Carbonaro; Gabriele Meli; Gianni Podda
Journal:  Molecules       Date:  2009-03-05       Impact factor: 4.411

8.  A New Hybrid δ-Lactone Induces Apoptosis and Potentiates Anticancer Activity of Taxol in HL-60 Human Leukemia Cells.

Authors:  Katarzyna Gach-Janczak; Joanna Drogosz-Stachowicz; Angelika Długosz-Pokorska; Rafał Jakubowski; Tomasz Janecki; Jacek Szymański; Anna Janecka
Journal:  Molecules       Date:  2020-03-25       Impact factor: 4.411

9.  Antiestrogenic Activity and Possible Mode of Action of Certain New Nonsteroidal Coumarin-4-acetamides.

Authors:  Maha S Almutairi; Areej N Al Suwayyid; Amal Aldarwesh; Omaima M Aboulwafa; Mohamed I Attia
Journal:  Molecules       Date:  2020-03-28       Impact factor: 4.411

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.